Answers are grounded in this paper and cite their sources.
Objective: To establish a standardized evidence-based approach to the management of malignant ovarian sex cord-stromal tumors (MOSCSTs) in Kenya. Methods: This protocol was developed by adapting high-quality international clinical practice guidelines to Kenya’s healthcare system and resource context. A multidisciplinary panel comprising gynecologic oncologists, pathologists, radiologists, oncology nurses, pharmacists, radiation oncologists, public health specialists, and patient representatives led the development process. Panel members received technical training from the University of Nairobi and Kenyatta National Hospital on evidence-based guideline adaptation, including standardized appraisal, systematic evaluation of guidelines, and contextualization to local needs. A systematic literature search was conducted in PubMed and Google Scholar. Five guidelines were identified and independently appraised using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. Four guidelines were selected for adaptation: the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology on ovarian cancer, including fallopian tube cancer and primary peritoneal cancer; the European Society for Medical Oncology (ESMO) clinical practice guidelines on non-epithelial ovarian cancer; the European Society of Gynaecological Oncology (ESGO) guidelines on non-epithelial ovarian cancers in adolescents and young adults; and the Japan Society of Gynecologic Oncology guidelines on ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. The selected guidelines were reviewed, and their recommendations were contextualized to Kenya’s healthcare infrastructure and available resources. Results: The protocol provides recommendations on clinical evaluation, histopathological assessment, staging, laboratory investigations, imaging, and the management of MOSCSTs. It addresses surgery as the primary treatment approach, the role of adjuvant and systemic therapies, and fertility-sparing management in selected patients with early-stage disease. It also covers the multidisciplinary management of advanced, recurrent, and treatment-resistant disease, post-treatment surveillance, survivorship, and supportive and palliative care. Recommendations: The protocol provides a standardized framework for the diagnosis, staging, treatment, and follow-up of MOSCSTs in Kenya. It emphasizes appropriate surgical management, individualized fertility-preserving approaches, multidisciplinary care, long-term surveillance, and referral for clinical trials where available, taking into account the patient’s clinical circumstances and the resources available.
No takes yet. Share an insight, caveat, or question.
Gitau et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: